Drug profile · INN
ropivacaine
ropivacaine is a sodium channel alpha subunit blocker.
NMPA: clinical trials
Patents linked 0
Pipeline programs 24
News articles 0
Drug details — ropivacaine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 24
- Data quality
- 0.70
Quick answer
ropivacaine is a sodium channel alpha subunit blocker.
Key facts
INN ropivacaine
Mechanism Sodium channel alpha subunit blocker
Mechanism of action
Sodium channel alpha subunit blocker
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is ropivacaine?
ropivacaine is a sodium channel alpha subunit blocker.